• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发和验证一种新的问卷,用于评估成人垂体功能减退症患者的生活质量:成人垂体功能减退症问卷(AHQ)。

Development and validation of a new questionnaire assessing quality of life in adults with hypopituitarism: Adult Hypopituitarism Questionnaire (AHQ).

机构信息

Department of Endocrinology, Tenri Hospital, Tenri, Japan.

出版信息

PLoS One. 2012;7(9):e44304. doi: 10.1371/journal.pone.0044304. Epub 2012 Sep 11.

DOI:10.1371/journal.pone.0044304
PMID:22984490
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3439490/
Abstract

OBJECTIVE

To develop and validate the Adult Hypopituitarism Questionnaire (AHQ) as a disease-specific, self-administered questionnaire for evaluation of quality of life (QOL) in adult patients with hypopituitarism.

METHODS

We developed and validated this new questionnaire, using a standardized procedure which included item development, pilot-testing and psychometric validation. Of the patients who participated in psychometric validation, those whose clinical conditions were judged to be stable were asked to answer the survey questionnaire twice, in order to assess test-retest reliability.

RESULTS

Content validity of the initial questionnaire was evaluated via two pilot tests. After these tests, we made minor revisions and finalized the initial version of the questionnaire. The questionnaire was constructed with two domains, one psycho-social and the other physical. For psychometric assessment, analyses were performed on the responses of 192 adult patients with various types of hypopituitarism. The intraclass correlations of the respective domains were 0.91 and 0.95, and the Cronbach's alpha coefficients were 0.96 and 0.95, indicating adequate test-retest reliability and internal consistency for each domain. For known-group validity, patients with hypopituitarism due to hypothalamic disorder showed significantly lower scores in 11 out of 13 sub-domains compared to those who had hypopituitarism due to pituitary disorder. Regarding construct validity, the domain structure was found to be almost the same as that initially hypothesized. Exploratory factor analysis (n = 228) demonstrated that each domain consisted of six and seven sub-domains.

CONCLUSION

The AHQ showed good reliability and validity for evaluating QOL in adult patients with hypopituitarism.

摘要

目的

开发并验证成人垂体功能减退症问卷(AHQ),作为一种针对成人垂体功能减退症患者的特定疾病、自我管理的生活质量(QOL)评估问卷。

方法

我们采用标准化程序开发和验证了这个新的问卷,该程序包括项目开发、预试验和心理测量验证。在参与心理测量验证的患者中,那些其临床状况被判断为稳定的患者被要求两次回答问卷调查,以评估测试-重测信度。

结果

通过两个预试验评估了初始问卷的内容有效性。在这些测试之后,我们进行了一些小的修订,最终确定了问卷的初始版本。该问卷由两个领域组成,一个是心理社会领域,另一个是身体领域。为了进行心理测量评估,对 192 名患有各种类型垂体功能减退症的成年患者的反应进行了分析。各个领域的组内相关系数分别为 0.91 和 0.95,Cronbach's alpha 系数分别为 0.96 和 0.95,表明每个领域都具有足够的测试-重测信度和内部一致性。对于已知组有效性,由于下丘脑障碍导致的垂体功能减退症患者在 13 个子领域中的 11 个领域的得分明显低于由于垂体障碍导致的垂体功能减退症患者。关于结构有效性,发现该领域的结构几乎与最初假设的相同。探索性因子分析(n=228)表明,每个领域由六个和七个子领域组成。

结论

AHQ 显示出良好的可靠性和有效性,可用于评估成人垂体功能减退症患者的 QOL。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7f5/3439490/76a2466debdf/pone.0044304.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7f5/3439490/76a2466debdf/pone.0044304.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7f5/3439490/76a2466debdf/pone.0044304.g001.jpg

相似文献

1
Development and validation of a new questionnaire assessing quality of life in adults with hypopituitarism: Adult Hypopituitarism Questionnaire (AHQ).开发和验证一种新的问卷,用于评估成人垂体功能减退症患者的生活质量:成人垂体功能减退症问卷(AHQ)。
PLoS One. 2012;7(9):e44304. doi: 10.1371/journal.pone.0044304. Epub 2012 Sep 11.
2
Validity and reliability of the Italian version of the ECOS-16 questionnaire in postmenopausal women with prevalent vertebral fractures due to osteoporosis.ECOS-16问卷意大利语版本在患有骨质疏松症所致椎体骨折的绝经后女性中的效度和信度
Clin Exp Rheumatol. 2007 May-Jun;25(3):390-403.
3
Psychometric validation of the French self and proxy versions of the PedsQL™ 4.0 generic health-related quality of life questionnaire for 8-12 year-old children.8-12 岁儿童 PedsQLTM 4.0 通用健康相关生活质量问卷自评和代评法语版的心理测量学验证。
Health Qual Life Outcomes. 2021 Mar 4;19(1):75. doi: 10.1186/s12955-021-01714-y.
4
Development and validation of a questionnaire for the assessment of the knowledge, management and reporting ADR in paediatrics by healthcare teams (QUESA-P).医疗团队用于评估儿科药物不良反应知识、管理及报告情况的问卷(QUESA-P)的开发与验证
BMJ Open. 2019 Oct 17;9(10):e028019. doi: 10.1136/bmjopen-2018-028019.
5
Craniofacial pain and disability inventory (CF-PDI): development and psychometric validation of a new questionnaire.颅面疼痛与功能障碍量表(CF-PDI):一种新问卷的编制及心理测量学验证
Pain Physician. 2014 Jan-Feb;17(1):95-108.
6
Perceived subject outcomes and impact on health-related quality of life associated with diet using the new Food Benefits Assessment (FBA) questionnaire: development and psychometric validation.使用新的食物益处评估(FBA)问卷对饮食相关的主观结果及对健康相关生活质量的影响:问卷的编制与心理测量学验证
Public Health Nutr. 2008 Nov;11(11):1163-72. doi: 10.1017/S1368980008001729. Epub 2008 Feb 18.
7
Psychometric Validation of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT) Questionnaire: Results of the SYMPHONY Trial.肺动脉高压症状和影响问卷(PAH-SYMPACT)的心理测量学验证:SYMPHONY 试验结果。
Chest. 2018 Oct;154(4):848-861. doi: 10.1016/j.chest.2018.04.027. Epub 2018 Apr 26.
8
Persian version of the brief Older People's Quality of Life questionnaire (OPQOL-brief): the evaluation of the psychometric properties.简要老年人生活质量问卷(OPQOL-brief)的波斯语版本:心理测量特性评估。
Health Qual Life Outcomes. 2020 Oct 7;18(1):327. doi: 10.1186/s12955-020-01586-8.
9
Development and psychometric validation of the Diabetes Therapy-Related QOL (DTR-QOL) questionnaire.糖尿病治疗相关生活质量(DTR-QOL)问卷的编制及心理测量学验证。
J Med Econ. 2012;15(3):556-63. doi: 10.3111/13696998.2012.665111. Epub 2012 Feb 23.
10
Quality of life after pulmonary embolism: Prospective validation of the German version of the PEmb-QoL questionnaire.肺栓塞后的生活质量:德语版PEmb-QoL问卷的前瞻性验证
Thromb Res. 2015 Jun;135(6):1087-92. doi: 10.1016/j.thromres.2015.03.031. Epub 2015 Apr 9.

引用本文的文献

1
Prevalence and risk of complications in untreated patients with adult growth hormone deficiency.成年生长激素缺乏未经治疗患者的并发症患病率及风险
Pituitary. 2025 Feb 18;28(2):32. doi: 10.1007/s11102-025-01500-9.
2
Panhypopituitarism Mimicking Acute Coronary Syndrome.全垂体功能减退症酷似急性冠状动脉综合征。
Intern Med. 2023 Feb 15;62(4):559-564. doi: 10.2169/internalmedicine.0031-22. Epub 2022 Jun 14.
3
Evaluation of a Novel General Pituitary Hormone Score to Evaluate the Function of the Residual Anterior Pituitary (Adenohypophysis) in Patients Following Surgery for Pituitary Adenoma.

本文引用的文献

1
Hypopituitarism.垂体功能减退症
Lancet. 2007 Apr 28;369(9571):1461-1470. doi: 10.1016/S0140-6736(07)60673-4.
2
Validation of the Japanese version of the Quality of Life-Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA).成人生长激素缺乏症生活质量评估量表(QoL-AGHDA)日语版的验证
Growth Horm IGF Res. 2006 Oct-Dec;16(5-6):340-7. doi: 10.1016/j.ghir.2006.09.002. Epub 2006 Nov 1.
3
Efficacy and safety of growth hormone (GH) in the treatment of adult Japanese patients with GH deficiency: a randomised, placebo-controlled study.
评价一种新的垂体激素总评分,以评估垂体瘤术后患者残留垂体前叶(腺垂体)的功能。
Med Sci Monit. 2018 Nov 6;24:7944-7951. doi: 10.12659/MSM.909925.
4
Change in quality of life in patients with acromegaly after treatment with octreotide LAR: first application of AcroQoL in Korea.奥曲肽长效注射剂治疗肢端肥大症患者后生活质量的变化:AcroQoL在韩国的首次应用
BMJ Open. 2015 Jun 10;5(6):e006898. doi: 10.1136/bmjopen-2014-006898.
5
Quality of life in the patients with central diabetes insipidus assessed by Nagasaki Diabetes Insipidus Questionnaire.通过长崎尿崩症问卷评估中枢性尿崩症患者的生活质量。
Endocrine. 2016 Jan;51(1):140-7. doi: 10.1007/s12020-015-0637-3. Epub 2015 May 30.
生长激素(GH)治疗成年日本生长激素缺乏症患者的疗效和安全性:一项随机、安慰剂对照研究。
Growth Horm IGF Res. 2006 Apr;16(2):132-42. doi: 10.1016/j.ghir.2006.03.012. Epub 2006 May 15.
4
The influence of growth hormone status on physical impairments, functional limitations, and health-related quality of life in adults.生长激素状态对成年人身体损伤、功能受限及健康相关生活质量的影响。
Endocr Rev. 2006 May;27(3):287-317. doi: 10.1210/er.2004-0022. Epub 2006 Mar 16.
5
Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures: report of the ISPOR Task Force for Translation and Cultural Adaptation.患者报告结局(PRO)测量指标翻译与文化调适过程的良好实践原则:国际药物经济学与结果研究协会(ISPOR)翻译与文化调适特别工作组报告
Value Health. 2005 Mar-Apr;8(2):94-104. doi: 10.1111/j.1524-4733.2005.04054.x.
6
Development and psychometric properties of a disease-specific quality of life questionnaire for adult patients with growth hormone deficiency.针对成年生长激素缺乏症患者的特定疾病生活质量问卷的开发及心理测量特性
Eur J Endocrinol. 2001 Sep;145(3):255-65. doi: 10.1530/eje.0.1450255.
7
Recommendations on health-related quality of life research to support labeling and promotional claims in the United States.关于在美国支持标签和促销声明的健康相关生活质量研究的建议。
Qual Life Res. 2000;9(8):887-900. doi: 10.1023/a:1008996223999.
8
The QoL-AGHDA: an instrument for the assessment of quality of life in adults with growth hormone deficiency.成人生长激素缺乏症患者生活质量评估量表(QoL-AGHDA):一种用于评估成人生长激素缺乏症患者生活质量的工具。
Qual Life Res. 1999 Jun;8(4):373-83. doi: 10.1023/a:1008987922774.
9
Psychometric and clinical tests of validity of the Japanese SF-36 Health Survey.日本SF-36健康调查的效度心理测量与临床测试。
J Clin Epidemiol. 1998 Nov;51(11):1045-53. doi: 10.1016/s0895-4356(98)00096-1.
10
Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan.用于日本的SF-36健康调查的翻译、改编及验证。
J Clin Epidemiol. 1998 Nov;51(11):1037-44. doi: 10.1016/s0895-4356(98)00095-x.